Drug profile · INN
rhtnk-tpa
rhtnk-tpa is a tissue-type plasminogen activator exogenous protein.
NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — rhtnk-tpa
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.70
Quick answer
rhtnk-tpa is a tissue-type plasminogen activator exogenous protein.
Key facts
INN rhtnk-tpa
Mechanism Tissue-type plasminogen activator exogenous protein
Target Tissue-type plasminogen activator
Mechanism of action
Tissue-type plasminogen activator exogenous protein
Primary target: Tissue-type plasminogen activator
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is rhtnk-tpa?
rhtnk-tpa is a tissue-type plasminogen activator exogenous protein.